VK
Veerendra Kumar
About Veerendra Kumar
Data last updated:
Veerendra Kumar is a Director at Mensun Pharmaceuticals Private Limited (since 2017) and Director at Medtas Pharmaceuticals Private Limited (since 2014). The companies operate in Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹2.18 Cr; the largest is Mensun Pharmaceuticals Private Limited at ₹1.49 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jul 2017 | 2017 | ₹1.49 Cr (FY 2025) | Active | |
| Director | 30 Sep 2014 | 2014 | ₹69.2 Lakh (FY 2020) | Active |
Board colleagues of Veerendra Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mangala | 07826078 | Mensun Pharmaceuticals Private Limited | Director |
| Ravi Kumar Pushpjivi | 06945212 | Medtas Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veerendra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veerendra Kumar
Veerendra Kumar currently holds 2 directorships: Mensun Pharmaceuticals Private Limited (Director, since 07 Jul 2017, revenue ₹1.49 Cr (FY 2025)); Medtas Pharmaceuticals Private Limited (Director, since 30 Sep 2014, revenue ₹69.2 Lakh (FY 2020)).
Veerendra Kumar was first appointed on 30 Sep 2014 as Director at Medtas Pharmaceuticals Private Limited. The most recent appointment on record is 07 Jul 2017 at Mensun Pharmaceuticals Private Limited.
The 2 current companies of Veerendra Kumar that report revenue have a combined latest revenue of ₹2.18 Cr: Mensun Pharmaceuticals Private Limited ₹1.49 Cr (FY 2025); Medtas Pharmaceuticals Private Limited ₹69.2 Lakh (FY 2020).
The current boards of Veerendra Kumar's companies include Mangala (Mensun Pharmaceuticals Private Limited), Ravi Kumar Pushpjivi (Medtas Pharmaceuticals Private Limited).